Natural killer (NK) cells are characterized by cytolytic activity against susceptible target cells and by the secretion of cytokines, such as tumor necrosis factor ␣ (TNF-␣) and interferon ␥ (IFN-␥). NK cells discriminate between normal and abnormal cells (infected or transformed) through engagement and dynamic integration of multiple signaling pathways, which are initiated by germline-encoded receptors. [1] [2] [3] Healthy cells are protected from NK-cell-mediated lysis by expression of major histocompatibility complex (MHC) class I ligands for NK-cellinhibitory receptors. 1, 4 However, de novo expression of ligands for NK-cell activation receptor NKG2D can trigger natural cytotoxicity against MHC class I ϩ target cells. 5, 6 A number of structurally distinct receptors have been implicated in activation of NK-cell effector functions. It is not yet clear if any one receptor is necessary or sufficient to activate NK cells and to what extent activation receptors may be redundant. Activation receptors can be grouped in 3 categories: receptors that signal through immunoreceptor tyrosine-based activation motif (ITAM)-containing subunits (eg CD16, NKp46, NKp44), the DAP10-associated receptor NKG2D, and several other receptors (eg CD2, 2B4, DNAM-1) that signal by different pathways.
Introduction
Natural killer (NK) cells are characterized by cytolytic activity against susceptible target cells and by the secretion of cytokines, such as tumor necrosis factor ␣ (TNF-␣) and interferon ␥ (IFN-␥). NK cells discriminate between normal and abnormal cells (infected or transformed) through engagement and dynamic integration of multiple signaling pathways, which are initiated by germline-encoded receptors. [1] [2] [3] Healthy cells are protected from NK-cell-mediated lysis by expression of major histocompatibility complex (MHC) class I ligands for NK-cellinhibitory receptors. 1, 4 However, de novo expression of ligands for NK-cell activation receptor NKG2D can trigger natural cytotoxicity against MHC class I ϩ target cells. 5, 6 A number of structurally distinct receptors have been implicated in activation of NK-cell effector functions. It is not yet clear if any one receptor is necessary or sufficient to activate NK cells and to what extent activation receptors may be redundant. Activation receptors can be grouped in 3 categories: receptors that signal through immunoreceptor tyrosine-based activation motif (ITAM)-containing subunits (eg CD16, NKp46, NKp44), the DAP10-associated receptor NKG2D, and several other receptors (eg CD2, 2B4, DNAM-1) that signal by different pathways.
CD16 (Fc␥RIII), a low-affinity receptor for IgG, is associated with the ITAM-containing Fc⑀RI ␥ chain and T-cell receptor (TCR) chain. NKp46 and NKp30 are associated with the TCR chain. 7 NKp44, KIR2DS, and CD94/NKG2C are associated with the ITAM-containing DAP12. Natural cytotoxicity receptors (NCRs), which include NKp46, NKp44, and NKp30, play a major role in NK-cell cytotoxicity against transformed cells. 8 Although ligands of NCRs have not been identified, antibodies against NCRs have been used to block lysis of tumor cells by interleukin 2 (IL-2)-activated and resting NK cells. [9] [10] [11] However, in the mouse, Syk/ ZAP70-independent natural cytotoxicity by NK cells was observed, implying that natural cytotoxicity can occur independently of ITAM-based activation signals. 12, 13 NKG2D can signal through both DAP10 and DAP12 in mice, 14, 15 whereas human NKG2D associates only with DAP10. [16] [17] [18] DAP10 is a signaling subunit that carries a phosphatidylinositol-3 kinase-binding motif. 16 Ligands for NKG2D, such as MICA and ULBP, are expressed on some tumor cells, and on infected or stressed cells. 19 Experiments have suggested that NKG2D signals are sufficient to activate NK-cell functions. [20] [21] [22] Lysis of certain tumor cells by resting NK cells and by IL-2-activated NK cells can be blocked by antibodies to NKG2D. 11, 23 The importance of ligands for NKG2D in immune defense is underscored by strategies developed by viruses to interfere with their expression. 19, 24, 25 Several other receptors activate NK cells by signaling through their own cytoplasmic tail. 2B4 (CD244) recruits SAP and Fyn through cytoplasmic tyrosine-based motifs. 26, 27 The ligand of 2B4 is CD48, which is expressed on hematopoietic cells. 28 CD2 and NKp80 signal through largely unknown pathways. CD2 binds to LFA-3 (CD58). 29 The ligand of NKp80 is unknown. DNAM-1 is associated with LFA-1 in NK cells, 30 is phosphorylated by a PKC, 31 and binds to CD155 and CD112. 32 Antibodies to DNAM-1 inhibit NK-cell cytotoxicity toward tumor cells. [32] [33] [34] Anti-CD16 mouse hybridomas are lysed by human NK cells in so-called redirected lysis assays, in which CD16 is cross-linked by surface IgG. 35, 36 Likewise, lysis of mouse FcR ϩ P815 cells, in a redirected, antibody-dependent lysis assays, by IL-2-activated human NK cells can be induced by independent engagement of CD16, 36, 37 NKp46, 38 NKp44, 39 NKp30, 10 NKp80, 40 NKG2D, 11,41  2B4, 42 CD2, 43 DNAM-1, 31 KIR2DS, 44 CD94/NKG2C, 45 and KIR2DL4, 46, 47 suggesting extensive redundancy in activation pathways. Most published studies have used polyclonal or clonal NK cells that have been expanded in IL-2. Because resting NK cells cannot be maintained very long in the absence of cytokines, much less is known about their requirements for activation of cytotoxicity and cytokine secretion. Here, we tested activation of resting NK cells by several receptors and by pair-wise combinations of receptors. For most NK-cell receptors, it is still unknown if they are capable of triggering NK-cell effector function independently or if they can only serve as costimulating receptors. Apart from the FcR CD16, which was sufficient for activation of cytotoxicity and cytokine release by resting NK cells, all NK-cell receptors tested required coengagement of another receptor for activation. Clear synergies between specific pairs of coactivating receptors were observed in the activation of cytotoxicity and cytokine secretion by resting NK cells.
Material and methods

Cells
Human NK-cell populations were isolated from peripheral blood by negative selection using an NK isolation kit (Miltenyi Biotec, Auburn, CA). Polyclonal IL-2-activated NK cells were expanded in Iscove modified Dulbecco medium (IMDM; Invitrogen, Carlsbad, CA) supplemented with 10% human serum (Valley Biomedical, Winchester, VA), 100 U/mL recombinant IL-2 (rIL-2; Hoffmann-La Roche, Basel, Switzerland), and 10% purified human IL-2 (Hemagen, Columbia, MD). Resting NK cells were resuspended in the same medium without IL-2 and were used within 1 to 4 days after isolation. These cells were 95% to 99% CD3 Ϫ CD56 ϩ as determined by flow cytometry. Prior to experiments, trypan blue exclusion was used to assess cell viability. After 4 days in culture, viability of resting NK cells was typically more than 90%. Cell-surface expression of activating receptors and the relative distribution of CD56 dim and CD56 bright NK cells did not change significantly during the culture. The mouse mastocytoma cell line P815 and the human erythroleukemia cell line K562 (both from American Type Culture Collection, Manassas, VA) were maintained in RPMI 1640 supplemented with 2 mM L-glutamine and 10% fetal bovine serum (FBS; all from Invitrogen).
Antibodies
For flow cytometric analysis, antibody-dependent redirected lysis, bead stimulation, and calcium flux measurements, the following monoclonal antibodies (mAbs; all mouse IgG1 isotype) were used: anti-CD2 (clone RPA-2.10), anti-CD3 (clone UCHT1), anti-CD16 (clone 3G8), anti-CD56 (clone B159), anti-CD107a (clone H4A3), anti-CD226/DNAM-1 (clone DX11), anti-NKG2D (clone 1D11), and isotype control (clone MOPC-21) from BD Biosciences (Franklin Lakes, NJ). Anti-CD244/2B4 (clone C1.7) and anti-NKp46 (clone BAB281) were from Beckman Coulter (Fullerton, CA). Anti-NKG2D (clone 149810) was from R&D Systems (Minneapolis, MN). Isotype control mouse IgG1 (clone MOPC-21) was from Sigma (St Louis, MO). Secondary goat F(abЈ) 2 anti-mouse IgG was from Jackson ImmunoResearch (West Grove, PA).
Cr-release assay
A standard 3-hour 51 Cr-release assay was performed as described. 48 Briefly, P815 or K562 target cells were labeled with 0.5 mCi/mL (19 MBq/mL) 51 Cr (Amersham Pharmacia, Piscataway, NJ) in saline solution for 1 hour at 37°C. Cells were washed 3 times in phosphate-buffered saline (PBS) and resuspended at 1 ϫ 10 6 cells/mL in IMDM supplemented with 10% FBS. P815 cells were incubated for 30 minutes at room temperature with 10 g/mL mAb. Cells were spun down, resuspended in medium, and plated at 1 ϫ 10 4 cells/well in triplicate. NK cells were washed, resuspended in IMDM supplemented with 10% FBS, and added to wells at the indicated effector-to-target (E/T) cell ratios. The supernatants were measured for 51 Cr release on a ␥-counter (Cobra II Auto-Gamma, Global Medical Instruments, Ramsey, MN).
Flow cytometric and single-cell Ca 2؉ flux analysis NK cells were stained with mAbs at 10 g/mL in 50 L Hanks buffered salt solution (HBSS) with Ca 2ϩ and Mg 2ϩ (Biosource, Camarillo, CA) supplemented with 1% FBS for 30 minutes on ice. Then 300 L dye-loading buffer (HBSS 1% FBS, 2 M Fluo-4 AM, 5 M Fura Red AM [both Molecular Probes, Eugene, OR] and 5 mM probenecid ) were added and cells were further incubated for 30 minutes on ice. Cells were pelleted by centrifugation and washed once in HBSS 1% FBS. Cells were kept on ice and resuspended in 300 L HBSS 1% FBS just prior to a 5-minute incubation in a waterbath at 37°C. Samples were vortexed and analyzed by flow cytometry (FACS Calibur, BD Bioscience). After 30 seconds, tubes were briefly removed, 4 g goat anti-mouse F(abЈ) 2 antibodies were added, samples were vortexed, placed back on the flow cytometer, and events were acquired for 4 minutes. Data were analyzed with FlowJo software (Treestar, Ashland, OR). NK cells were gated on forward scatter/side scatter plots. The ratio between the mean fluorescence intensity of FL-1 and FL-3 was calculated and plotted as a function of time. The baseline for isotype control-stimulated cells was set to 1, and this factor was used to normalize the other plots in every batch.
For microscopic single-cell analysis, resting NK cells were resuspended in culture medium containing 0.4 M Fluo-4 AM, 4 M Fura Red AM, and 5 mM probenecid at 2 ϫ 10 6 cells/mL and incubated at room temperature for 30 minutes. The cells were washed once in HBSS 1% FBS and resuspended at 2 ϫ 10 6 cells/mL in HBSS 1% FBS. Aliquots of 0.5 mL were added to poly-L-lysine-coated (Sigma) wells of Lab-Tek II chambered coverglasses (Nunc, Roskilde, Denmark). The cells were allowed to settle onto the coverglass for 15 minutes at room temperature. The medium was aspirated from the chambers and replaced with 300 L cold HBSS 1% FBS containing 3 g of each of the appropriate mAbs. The chambers were incubated for 30 minutes on ice. Cells were washed once with 1 mL cold HBSS 1% FBS, and 400 L cold HBSS 1% FBS was placed in each chamber. Prior to acquisition on the confocal microscope, each chamber was warmed in a 37°C, 5% CO 2 incubator for 5 minutes. Data were acquired on a Zeiss LSM510 confocal microscope using a ϫ 40 oilimmersion lens (Zeiss, Göttingen, Germany). The microscope was set in scan mode so that wavelengths from 499 to 670 nm were acquired in a single pass. The pinhole was adjusted so that optic slices of approximately 2 m were acquired. Scan speed was set so that one scan was completed every 4 seconds. Thirty seconds after the beginning of acquisition, secondary cross-linking goat anti-mouse F(abЈ) 2 antibody was added to a final concentration of 13 g/mL. Scanning was continued for 10 minutes. After acquisition was complete, the data were processed by linear unmixing, using control spectra acquired from cells loaded individually with either Fluo-4 or Fura-Red. After unmixing, individual cells were analyzed to give the fluorescence values of the Fluo-4 and Fura Red for the entire time series, which were used to calculate the ratio of the Fluo-4 fluorescence to the Fura Red fluorescence.
CD107a degranulation assay
P815 cells (2 ϫ 10 5 ) were incubated for 15 minutes at room temperature with 5 g/mL mAbs. Cells were spun down and resuspended with 1 ϫ 10 5 resting NK cells in IMDM supplemented with 10% FBS. Cells were spun down for 3 minutes at 17g and incubated for 2 hours at 37°C. Thereafter, cells were spun down and cell pellets were resuspended in PBS 2% FBS and stained with PE-conjugated anti-CD56 and FITC-conjugated anti-CD107a mAbs, followed by flow cytometric analysis.
Bead stimulation and ELISA
Beads with a diameter of 4.5 m were used to stimulate NK cells at a ratio of 8 beads per cell. To coat beads with saturating amounts of mAb, 4 ϫ 10 7 goat anti-mouse-coated beads (Dynabeads M-450; Dynal, Oslo, Norway) were incubated with 3 g premixed mAbs in PBS 2% FBS for 1 hour at 4°C. Beads were washed 3 times in PBS 2% FBS to remove excess mAbs. For cell stimulation, 4 ϫ 10 6 beads were incubated with 5 ϫ 10 5 resting NK cells in 500 L IMDM supplemented with 10% human serum for 2 or 6 hours at 37°C. The cultures were rotated end-over-end during the stimulation. Supernatants were stored at Ϫ20°C and analyzed with TNF-␣ enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems) or IFN-␥ ELISA kit (Pierce, Rockford, IL).
Results
Induction of cytotoxicity by receptors on resting NK cells
Cytotoxicity by IL-2-activated NK cells and by resting NK cells was compared in redirected, lysis assays. The mouse FcR ϩ cell line P815 was incubated with mAbs to several NK-cell receptors and mixed with NK cells. 51 Cr release by P815 cells at several E/T cell ratios was measured after 3 hours (Figure 1 ). In several independent experiments, up to 20% lysis was observed when P815 cells were incubated with IL-2-activated NK cells at an E/T cell ratio of 10 (not shown). This lysis was not enhanced by the presence of isotype control IgG1 (11% Ϯ 8.0% [mean Ϯ SD] specific lysis at an E/T ratio of 10:1, 5 independent experiments), and of mAbs to CD56 or CD2 ( Figure 1A) . The mAbs to CD16, NKp46, NKG2D, 2B4, and DNAM-1 each augmented lysis of P815 target cells in the presence of IL-2-activated NK cells ( Figure 1A) . Notably, at lower E/T cell ratios, CD16 was the strongest inducer of cytotoxicity by IL-2-activated NK cells ( Figure 1A ).
Freshly isolated, resting NK cells did not induce lysis of P815 cells either in the absence (not shown) or in the presence of isotype control IgG1 (1.0% Ϯ 1.8% specific lysis at an E/T cell ratio of 10:1; n ϭ 7; Figure 1B) . A mAb to CD16 induced 35% to 65% lysis of P815 cells at an E/T cell ratio of 10 (51% Ϯ 13% specific lysis; n ϭ 7). The mAbs to NKp46, NKG2D, 2B4, CD2, DNAM-1, or CD56 induced little or no lysis of P815 target cells ( Figure 1B) . With freshly isolated NK cells from some donors, up to 10% lysis with mAb to 2B4 (6.9% Ϯ 4.7% specific lysis at an E/T cell ratio of 10:1, n ϭ 7) or DNAM-1 (5.2% Ϯ 4.9% specific lysis at an E/T cell ratio of 10:1; n ϭ 6) was observed. Less lysis was observed with a mAb to NKp46 (2.0% Ϯ 1.7% specific lysis at an E/T cell ratio of 10:1, n ϭ 6). No lysis was observed with NK cells from any donor with mAbs to NKG2D, CD2, and CD56 ( Figure 1B) .
In some instances, natural ligands of NKG2D activated NK cells more efficiently than mAbs to NKG2D. 49 
Synergistic activation of intracellular Ca 2؉ mobilization in resting NK cells by pair-wise combinations of receptors
Intracellular Ca 2ϩ concentration was measured in resting NK cells after cross-linking different receptors. NKp46, 2B4, NKG2D, and DNAM-1 are expressed on all NK cells. CD16 is expressed on NK cells of the CD56 dim subset, which represented more than 90% of the total NK cell population. Therefore, analysis of activation by these receptors was performed on a forward scatter/side scatter gate for total NK cells. Because CD2 is expressed on a subset of resting NK cells, cells were stained with PE-conjugated anti-CD2 and gated on CD2 bright cells. To investigate the relative potency of individual receptors and the effect of co-crosslinking different receptor combinations, time-course analysis was performed with resting NK cells preincubated with mAbs to a single receptor or to pair-wise combinations of receptors. Cells were loaded with the Ca 2ϩ sensitive dyes Fluo-4 and Fura Red and analyzed by flow cytometry (Figure 3 ). After acquisition of baseline fluorescence, secondary goat F(abЈ) 2 antimouse fragments were added to crosslink receptors. The FL-1/FL-3 ratio was recorded over 4 minutes ( Figure 3A) . The mean peak FL-1/FL-3 value from several independent experiments was also calculated ( Figure 3B ). The mAb to CD16 elevated baseline Ca 2ϩ without cross-linking, and Figure 3A) . Cross-linking of NKp46 and of 2B4 also led to rises in intracellular Ca 2ϩ , but the peak FL-1/FL-3 ratios were significantly lower and the kinetics were slower than responses elicited by CD16 cross-linking (Figure 3 ). Cross-linking of mAb to NKG2D or DNAM-1 induced only a very small but reproducible rise in intracellular Ca 2ϩ . Cross-linking CD2 produced only minor elevations in intracellular Ca 2ϩ ( Figure 3 ) and cross-linking of CD56 did not produce any rises in Ca 2ϩ ( Figure 3B and data not shown).
Co-crosslinking CD16 with NKG2D, 2B4, CD2, or DNAM-1 enhanced the peak Ca 2ϩ (Figure 3 ). Co-cross-linking with the other ITAM-containing receptor NKp46 (Figure 3 ) or with CD56 (not shown) did not enhance Ca 2ϩ flux. Although NKp46 mAb induced modest elevations in Ca 2ϩ by itself, co-crosslinking with mAbs to NKG2D, 2B4, CD2, or DNAM-1 significantly increased the rise in intracellular Ca 2ϩ (Figure 3 ). 2B4 induced significant elevations in intracellular Ca 2ϩ in combination with CD16, NKp46, NKG2D, or DNAM-1, but not with CD2 or CD56 (Figure 3 and data not shown). NKG2D cross-linking synergized with CD16, NKp46, or 2B4. A small enhancement was also observed when NKG2D and DNAM-1 were co-crosslinked, but no synergy was observed on cross-linking with CD2 ( Figure 3) . Cross-linking CD2 and DNAM-1 did not produce any significant rise in intracellular Ca 2ϩ ( Figure 3) . These results revealed a complex pattern of synergy among receptors in activation of resting NK cells.
Flow cytometry cannot follow the kinetics of Ca 2ϩ regulation in individual cells. Recording of Ca 2ϩ fluctuations in individual T cells revealed important differences in functional outcome of oscillating versus sustained Ca 2ϩ fluxes. 50 We performed microscopy experiments to follow intracellular Ca 2ϩ responses elicited in individual NK cells after receptor cross-linking or co-crosslinking (Figure 4) . Resting NK cells were placed on poly-L-lysine-coated coverslips, incubated with mAbs, and loaded with Ca 2ϩ -sensitive dyes Fluo-4 and Fura Red. Recordings of individual cells revealed that CD16 cross-linking elicited varied responses ( Figure 4A ), in comparison to baseline Ca 2ϩ fluctuations observed with isotype control mAb-treated cells ( Figure 4B) . In some cells, CD16 cross-linking induced a sharp but transient rise in intracellular Ca 2ϩ . In other cells, lower peaks but more oscillation was observed. Whereas NKG2D cross-linking produced little or no rise in baseline intracellular Ca 2ϩ ( Figure 4C ), cross-linking of CD16 and NKG2D resulted in a more sustained elevation in Ca 2ϩ in most cells ( Figure 4D ). Cross-linking of 2B4 induced sustained rises in intracellular Ca 2ϩ ( Figure 4E ), and these were further enhanced by co-crosslinking with NKG2D ( Figure 4F ). Overall, data match those obtained by flow cytometry.
In conclusion, each receptor is capable of contributing a signal in resting NK cells, which results in Ca 2ϩ mobilization when costimulated by another receptor. Some receptors can elicit Ca 2ϩ flux directly, in the absence of adhesion or coengagement of other receptors.
Synergistic Ca 2؉ flux correlates with degranulation
Phospholipase C-␥ activation and Ca 2ϩ mobilization are among the early steps leading to perforin-dependent NK-cell cytotoxicity. 51 Exocytosis of secretory lysosomes, which are lytic granules, is required to complete this process. An assay was used to measure degranulation based on cell-surface expression of the lysosomal protein CD107a (LAMP-1). 52 Resting NK cells did not stain with anti-CD107a mAb, relative to isotype control mAb staining, and incubation with P815 cells and isotype control antibody did not induce CD107a surface expression ( Figure 5 ). When NK cells were incubated with anti-CD16 mAb and FcR ϩ P815 cells for crosslinking, CD107a expression was detected on 50% of the NK cells (52% Ϯ 9.2% [mean Ϯ SD] of CD107a ϩ CD56 ϩ NK cells, 7 independent experiments; Figure 5 ). Notably, degranulation was observed on the CD56 dim CD16 ϩ but not the CD56 bright CD16 Ϫ NK-cell subset ( Figure 5 ). Alone, anti-NKG2D and anti-2B4 mAbs did not induce surface expression of CD107a (1.3% Ϯ 0.6% and 2.7% Ϯ 1.3%, respectively, 7 independent experiments; Figure 5 ). Therefore, CD107a surface expression correlated with the observed cytolytic activity by resting NK cells ( Figure 1B) . When resting NK cells were incubated with a combination of anti-CD16 and anti-NKG2D mAbs, CD107a surface expression increased somewhat relative to that induced by anti-CD16 mAb alone (56% Ϯ 8.3%, 7 independent experiments; Figure 5 ). Interestingly, the combination of anti-NKG2D and anti-2B4 mAbs induced a synergistic increase in CD107a surface expression (13% Ϯ 6.1%, 7 independent experiments; Figure 5 ), correlating with the observed synergy for Ca 2ϩ flux.
Stimulation of TNF-␣ and IFN-␥ secretion
To evaluate which receptor or receptor combination could induce cytokine secretion, resting NK cells were incubated for 2 hours at 37°C with beads coated with mAbs to NK-cell receptors. TNF-␣ secretion was quantified by ELISA. The mAb to CD16 was sufficient to induce TNF-␣ secretion by resting NK cells ( Figure 6A ). By comparison, mAbs to other receptors did not induce TNF-␣ secretion ( Figure 6A) . Therefore, the difference between CD16 and the other receptors was even more striking than it had been in Ca 2ϩ flux measurements. All pair-wise combinations of mAbs were tested for induction of TNF-␣ secretion ( Figure 6A ). In these experiments, mAbs to 2 receptors were added together on the same beads. NKp46 synergized with NKG2D, 2B4, and CD2, and to a lesser extent Figure 6A ). In addition, clear synergy was observed between NKG2D and 2B4, 2B4 with DNAM-1, and 2B4 with CD2 ( Figure 6A ). Weaker stimulations were obtained with combinations of NKG2D, CD2, and DNAM-1 ( Figure 6A) . Therefore, synergies similar to those observed for the induction of Ca 2ϩ flux occurred for the induction of TNF-␣ secretion. Secretion of IFN-␥ was also measured after a 6-hour stimulation ( Figure 6B ). In repeated experiments, secretion of IFN-␥ responded to the same combinations of receptor signals as TNF-␣.
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Cytotoxicity induced by pair-wise combinations of receptors
To test whether combinations of receptors that synergize to activate Ca 2ϩ flux and cytokine secretion could also signal for cytotoxicity by resting NK cells, the redirected lysis assay shown in Figure 1 was used. All pair-wise combinations of receptors were tested for lysis at an E/T cell ratio of 10 ( Figure 6C ). The strongest synergies were observed with 2B4 in combination with NKp46, NKG2D, and DNAM-1. In addition, as seen with induction of Ca 2ϩ flux and cytokine secretion, receptor NKp46 synergized with all other receptors. Overall, the pattern of synergies ( Figure 7 ) was similar in all assays used. We conclude that resting NK cells are quite capable of killing target cells, given the right combination of signals. Furthermore, of all the receptors tested, each one is capable of contributing a signal in resting NK cells.
Discussion
The data presented here show that responses by resting NK cells, in the absence of exogenous cytokines, can be induced by combinations of activation receptors. Responses measured were Ca 2ϩ flux triggered by cross-linked mAbs in solution, TNF-␣ and IFN-␥ secretion induced by mAbs attached to beads, and cytotoxicity against an FcR ϩ target cell in the presence of mAbs directed to NK-cell activation receptors. Except for the FcR CD16, which mediates antibody-dependent cellular cytotoxicity (ADCC) and not natural cytotoxicity, no single receptor tested-NKp46, NKG2D, 2B4, DNAM-1, or CD2-was sufficient to activate considerable cytotoxicity or cytokine secretion. However, each one of these receptors contributes a signal in resting NK cells, as shown by synergistic activation by specific pair-wise combinations of receptors. Resting NK cells are not inherently less responsive than IL-2-activated NK cells, but the regulation of their activation is more stringent.
A hierarchy among receptors for the activation of resting NK cells was revealed. CD16 was unique in its ability to induce cytokine secretion by resting NK cells without additional signals. With regard to cytotoxicity, it is possible that recognition of mouse ligands on P815 cells by human NK cells contributes to activation. P815 cells express mouse ICAM-1, which is a ligand for human LFA-1. 53 Blocking antibodies to LFA-1 reduced the CD16-mediated cytotoxicity toward target cells. 35 In Ca 2ϩ flux experiments, activation by CD16 was enhanced by all other receptors, except NKp46, suggesting that ITAM-based signals do not enhance one another. The results imply a difference in signaling via the ITAM chains associated with CD16 and those associated with NKp46. The mAb to NKp46, in the absence of further crosslinking, was not sufficient to mobilize Ca 2ϩ in resting NK cells. Further, cross-linking of NKp46 resulted in lower Ca 2ϩ flux as compared to CD16. CD16 associates with ITAM-containing chain (Fc⑀RI ␥ and TCR ) complexes through a negatively charged aspartate residue in the transmembrane, whereas NKp46 has a positively charged arginine residue in the transmembrane. Crosslinking of NKp46 on resting NK cells was insufficient for full activation, but if provided with additional signals, NKp46 can potentiate activation. NKp46 ranks high in the hierarchy, but below CD16, because it synergizes with all 4 other receptors. The observed synergies among receptors involved in natural cytotoxicity are depicted in Figure 7 .
2B4 synergizes with the 3 receptors, NKp46, NKG2D, and DNAM-1. NKG2D and DNAM-1 each synergize with the 2 receptors, NKp46 and 2B4. Finally, CD2 is unique in its exclusive synergy with ITAM-associated receptors. Although the signaling pathways for most of these receptors are still poorly understood, evidence indicates that each receptor signals by different pathways. 54, 55 The NKG2D/DAP10 complex activates phosphatidylinositol-3 kinase, phospholipase C-␥ and Vav. 22 2B4 recruits SAP and Fyn, through phosphorylated tyrosine motifs. 26,27 DNAM-1 is associated with LFA-1 in NK cells and is phosphorylated by PKC. 30, 31 CD2 binds the adaptor protein CD2AP, as shown in T cells, and provides a link to Wiskott-Aldrich syndrome proteinmediated actin cytoskeleton remodeling. 56, 57 The unique pattern of receptor combinations that provide synergy is consistent with the use of different signaling modules by each receptor to induce activation. It will be necessary to identify signaling components for each of the receptors to determine the basis for the synergies.
Our data have revealed a complex hierarchy, synergy, and redundancy among activation receptors on NK cells. A hierarchy of CD16 Ͼ NKp46 Ͼ 2B4 Ͼ NKG2D, DNAM-1 Ͼ CD2 can be established on the basis of requirements for NK-cell activation. It should be noted that CD16 is not a natural cytotoxicity receptor. CD16 mediates ADCC, which leads to the elimination of antibodycoated target cells. Because different combinations of different signals can each result in activation of NK-cell function, including natural cytotoxicity, redundancy is apparent. For example, the combination of NKp46 and CD2 is sufficient to activate, but the combination of 2 other signals, such as DNAM-1 and 2B4, can also activate. It is likely that this kind of redundancy forms the basis for the natural cytotoxicity observed with NK cells from mice with a double Syk/ZAP70 deficiency, even on target cells that lacked ligands for NKG2D. 12 Several combinations of signals, excluding ITAM-and DAP10-based signals, are still available that can result in activation of cytotoxicity.
Activation of resting NK cells by synergistic signals raises the issue of terminology used to describe NK-cell receptors. NK cells do not have a dominant activation receptor, in the sense used to describe the TCR, except for the ADCC induced by CD16. NK cells use combinations of synergistic receptors to mediate natural cytotoxicity. The term "costimulation" could be confusing because it means something different in the context of T cells. "Coactivation" receptors may be a useful term to describe the NK-cell activation receptors studied here.
The importance of a tight regulation of natural cytotoxicity by inhibitory receptors on NK cells is obvious, considering that ligands for several of the coactivation receptors are widely expressed. LFA-3 (CD58), the ligand for CD2, is broadly expressed, whereas expression of CD48, a ligand for 2B4, is confined to hematopoietic cells and a subset of endothelial cells. 58 Ligands for DNAM-1, CD155 and CD112, are transcribed in a wide variety of tissues. 59, 60 Ligands of NKp46 and of other NCRs have not been identified yet, but may include a carbohydrate component. [61] [62] [63] Cells that have up-regulated expression of ligands for NKG2D become sensitive to lysis by NK cells. Our data suggest that NKG2D does not signal alone but provides a coactivation signal to pre-existing signals from other receptors, such as 2B4 and NCRs. Thus, the induced expression of ligands for NK-cell receptors may suffice to override the balance between activation and inhibition. The distribution of ligands in vivo must determine degrees of sensitivity to NK cells. Some of the most widely expressed ligands are those for receptors DNAM-1, CD2, and NKG2D. Combinations of these receptors did not produce robust NK-cell activation. We propose that a more restricted expression of ligands for 2B4, NKp46, and other NK-cell receptors with similar coactivation potential could confine NK-cell alloreactivity to hematopoietic cells. 
